• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于罕见同步肿瘤的反向转化方法鉴定恶性胸膜间皮瘤的新型诊断标志物

Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor.

作者信息

Naka Tomoaki, Hatanaka Yutaka, Tabata Yukiko, Takasawa Akira, Akiyama Hideo, Hida Yasuhiro, Okada Hiromi, Hatanaka Kanako C, Mitsuhashi Tomoko, Kushitani Kei, Amatya Vishwa Jeet, Takeshima Yukio, Inai Kouki, Kaga Kichizo, Matsuno Yoshihiro

机构信息

Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8648, Japan.

Department of Diagnostic Pathology, Faculty of Medicine, Hokkaido University, Sapporo 060-8638, Japan.

出版信息

Diagnostics (Basel). 2022 Jan 27;12(2):316. doi: 10.3390/diagnostics12020316.

DOI:10.3390/diagnostics12020316
PMID:35204409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8871196/
Abstract

Although the routine use of immunohistochemistry has improved the accuracy of histopathologic diagnosis in clinical practice, new methods for discovering novel diagnostic markers are still needed. We sought new diagnostic markers for malignant pleural mesothelioma (MPM) using a reverse translational approach with limited archival tissues from a very rare case. Total RNA extracted from formalin-fixed paraffin-embedded (FFPE) tissues of a synchronous collision tumor consisting of MPM and pulmonary adenocarcinoma (PAC) was employed for gene expression profiling (GEP) analysis. Among the 54 genes selected by GEP analysis, we finally identified the following two candidate MPM marker genes: and . Immunohistochemical analysis of 48 MM and 20 PAC cases showed that both PHGDH and TRIM29 had sensitivity and specificity almost equivalent to those of calretinin (sensitivity 50% and 46% vs. 63%, and specificity 95% and 100% vs. 100%, respectively). Importantly, of the 23 epithelioid MMs, all 3 calretinin-negative cases were positive for TRIM29. These two markers may be diagnostically useful for immunohistochemical distinction between MPMs and PACs. This successful reverse translational approach based on FFPE samples from one very rare case encourages the further use of such samples for the development of novel diagnostic markers.

摘要

尽管免疫组织化学的常规应用提高了临床实践中组织病理学诊断的准确性,但仍需要发现新型诊断标志物的新方法。我们采用反向转化方法,利用来自一例极为罕见病例的有限存档组织,寻找恶性胸膜间皮瘤(MPM)的新型诊断标志物。从由MPM和肺腺癌(PAC)组成的同步碰撞肿瘤的福尔马林固定石蜡包埋(FFPE)组织中提取的总RNA用于基因表达谱(GEP)分析。在GEP分析选择的54个基因中,我们最终鉴定出以下两个MPM候选标志物基因: 和 。对48例MPM和20例PAC病例的免疫组织化学分析表明,磷酸甘油酸脱氢酶(PHGDH)和三聚体基序蛋白29(TRIM29)的敏感性和特异性几乎与钙视网膜蛋白相当(敏感性分别为50%、46%和63%,特异性分别为95%、100%和100%)。重要的是,在23例上皮样MPM中,所有3例钙视网膜蛋白阴性病例的TRIM29均为阳性。这两种标志物在MPM和PAC的免疫组织化学鉴别诊断中可能具有实用价值。这种基于一例极罕见病例的FFPE样本的成功反向转化方法,鼓励进一步利用此类样本开发新型诊断标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/46f6eddd8692/diagnostics-12-00316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/231c83d1ecd8/diagnostics-12-00316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/44394582c4e5/diagnostics-12-00316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/6fe32f5b4e62/diagnostics-12-00316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/46f6eddd8692/diagnostics-12-00316-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/231c83d1ecd8/diagnostics-12-00316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/44394582c4e5/diagnostics-12-00316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/6fe32f5b4e62/diagnostics-12-00316-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68e8/8871196/46f6eddd8692/diagnostics-12-00316-g004.jpg

相似文献

1
Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor.基于罕见同步肿瘤的反向转化方法鉴定恶性胸膜间皮瘤的新型诊断标志物
Diagnostics (Basel). 2022 Jan 27;12(2):316. doi: 10.3390/diagnostics12020316.
2
Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.由恶性胸膜间皮瘤和原发性肺腺癌组成的罕见同步碰撞肿瘤的比较基因分析。
Diagn Pathol. 2016 Apr 18;11:38. doi: 10.1186/s13000-016-0488-0.
3
Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma.通过转录组微阵列分析鉴定DAB2和抗酒石酸酸性磷酸酶1作为上皮样间皮瘤的新型阳性免疫组织化学标志物以用于其与肺腺癌的鉴别诊断
Am J Surg Pathol. 2017 Aug;41(8):1045-1052. doi: 10.1097/PAS.0000000000000852.
4
How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab.如何在病理实验室评估用于诊断恶性胸膜间皮瘤的最佳免疫组织化学检测组合。
J Immunoassay Immunochem. 2018;39(3):263-273. doi: 10.1080/15321819.2018.1472606. Epub 2018 May 14.
5
Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells.人黏膜相关上皮趋化因子-1 在恶性胸膜间皮瘤和胃肠道杯状细胞中的特异性表达。
PLoS One. 2012;7(7):e39889. doi: 10.1371/journal.pone.0039889. Epub 2012 Jul 2.
6
Genomic Deletion of and Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures.基因组缺失 和 是恶性胸膜间皮瘤(MPM)原代培养物质量控制的有用标志物。
Int J Mol Sci. 2018 Oct 7;19(10):3056. doi: 10.3390/ijms19103056.
7
Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.新型标志物D2-40联合钙视网膜蛋白、癌胚抗原和甲状腺转录因子-1:胸膜间皮瘤的最佳免疫诊断标志物组合。
Cancer. 2007 Mar 1;109(5):933-8. doi: 10.1002/cncr.22477.
8
Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma.紧密连接蛋白3、4和15在肺腺癌与恶性胸膜间皮瘤实体瘤中的表达
Ann Diagn Pathol. 2015 Aug;19(4):193-7. doi: 10.1016/j.anndiagpath.2015.03.007. Epub 2015 Apr 14.
9
Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.恶性胸膜间皮瘤转移至纵隔淋巴结的不寻常特征。
Appl Immunohistochem Mol Morphol. 2008 May;16(3):301-7. doi: 10.1097/PAI.0b013e3181507893.
10
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.微小RNA-130A作为在胸腔积液细胞学中区分恶性间皮瘤与肺腺癌的诊断标志物。
Cancer Cytopathol. 2017 Aug;125(8):635-643. doi: 10.1002/cncy.21869. Epub 2017 Apr 27.

本文引用的文献

1
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma.恶性胸膜间皮瘤中过表达基因的鉴定。
Int J Mol Sci. 2021 Mar 8;22(5):2738. doi: 10.3390/ijms22052738.
2
Potential years of life and productivity loss due to malignant mesothelioma in Turkey.土耳其恶性间皮瘤导致的潜在生命年数和生产力损失。
Arch Environ Occup Health. 2020;75(8):464-470. doi: 10.1080/19338244.2020.1747380. Epub 2020 Apr 13.
3
Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology: A Gene Expression Panel versus BRCA1-Associated Protein 1 and p16 Tests.
细胞病理学中恶性胸膜间皮瘤的鉴别诊断:基因表达谱面板与 BRCA1 相关蛋白 1 和 p16 检测的比较。
J Mol Diagn. 2020 Apr;22(4):457-466. doi: 10.1016/j.jmoldx.2019.12.009. Epub 2020 Feb 7.
4
ATDC mediates a TP63-regulated basal cancer invasive program.ATDC 介导了一个由 TP63 调控的基底细胞癌侵袭程序。
Oncogene. 2019 May;38(18):3340-3354. doi: 10.1038/s41388-018-0646-9. Epub 2019 Jan 14.
5
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.通过抑制磷酸甘油酸脱氢酶克服 EGFR 突变阳性肺腺癌中的厄洛替尼耐药性。
Theranostics. 2018 Feb 12;8(7):1808-1823. doi: 10.7150/thno.23177. eCollection 2018.
6
Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.恶性胸膜间皮瘤中的过表达基因:对临床管理的意义。
J Thorac Dis. 2018 Jan;10(Suppl 2):S369-S382. doi: 10.21037/jtd.2017.10.158.
7
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis.PHGDH在预后不良的肺腺癌中定义了一种代谢亚型。
Cell Rep. 2017 Jun 13;19(11):2289-2303. doi: 10.1016/j.celrep.2017.05.067.
8
MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.MUC4是一种通过基因表达谱鉴定出的新型免疫组化标志物,可将胸膜肉瘤样间皮瘤与肺肉瘤样癌区分开来。
Mod Pathol. 2017 May;30(5):672-681. doi: 10.1038/modpathol.2016.181. Epub 2017 Jan 27.
9
High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer.磷酸甘油酸脱氢酶高表达预示非小细胞肺癌预后不良。
Transl Oncol. 2016 Dec;9(6):592-599. doi: 10.1016/j.tranon.2016.08.003.
10
Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.由恶性胸膜间皮瘤和原发性肺腺癌组成的罕见同步碰撞肿瘤的比较基因分析。
Diagn Pathol. 2016 Apr 18;11:38. doi: 10.1186/s13000-016-0488-0.